Search

Despite Pain Drug's Mid-Stage Miss, Adynxx Plans a Larger Phase 3 Test

DESPITE PAIN DRUG'S MID-STAGE MISS, ADYNXX PLANS A LARGER PHASE 3 TEST

An Adynxx pain drug has failed to meet the main goal of a mid-stage study, but the company instead points to results in a subset of...

 
 
 
Pain Drug Developer Adynxx Picks Up $16M for Another Clinical Trial

PAIN DRUG DEVELOPER ADYNXX PICKS UP $16M FOR ANOTHER CLINICAL TRIAL

Despite the wide range of pain relievers available, many patients find these drugs fall short of easing pain after surgery and during...